New Potomac Partners, LLC Gilead Sciences, Inc. Transaction History

New Potomac Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$63.47 - $69.35 $969,504 - $1.06 Million	-15,275 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $604,682 - $689,006	-10,674 Reduced 41.13%	15,275 $890,000
Q3 2020 Oct 23, 2020	SELL	$62.1 - $78.08 $25,212 - $31,700	-406 Reduced 1.54%	25,949 $1.64 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $78,850 - $91,560	-1,090 Reduced 3.97%	26,355 $2.03 Million
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $49,790 - $63,774	-795 Reduced 2.82%	27,445 $2.05 Million
Q4 2019 Jan 23, 2020	BUY	$61.62 - $67.78 $1.74 Million - $1.91 Million	28,240 New	28,240 $1.84 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on New Potomac Partners, LLC with notifications on news.